High hemoglobin A1c levels within the non-diabetic range are associated with the risk of all cancers

International Journal of Cancer

Volumn 138, Issue 7, 2016, Pages 1741-1753

  Goto, Atsushi ^a,b   Noda, Mitsuhiko ^a,c   Sawada, Norie ^d   Kato, Masayuki ^a   Hidaka, Akihisa ^d   Mizoue, Tetsuya ^a   Shimazu, Taichi ^d   Yamaji, Taiki ^d   Iwasaki, Motoki ^d   Sasazuki, Shizuka ^d   Inoue, Manami ^d,e   Kadowaki, Takashi ^e   Tsugane, Shoichiro ^d  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

cancer incidence; diabetes mellitus; hemoglobin A1c; hyperglycemia

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENERGY CONSUMPTION; FEMALE; FOLLOW UP; GENDER; GEOGRAPHIC DISTRIBUTION; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOCHEMISTRY; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PANCREAS CANCER; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECTUM CANCER; RISK ASSESSMENT; SMOKING; STOMACH CANCER; VERY ELDERLY; BLOOD; INCIDENCE; JAPAN; NEOPLASMS; RISK FACTOR;

AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84955592865     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29917     Document Type: Article

References (45)

1. Inoue M, Iwasaki M, Otani T, et al., Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871-7.
2. Sasazuki S, Charvat H, Hara A, et al., Diabetes mellitus and cancer risk: pooled analysis of eight cohort studies in Japan. Cancer Sci 2013; 104: 1499-507.
3. Giovannucci E, Harlan DM, Archer MC, et al., Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-85.
4. Kasuga M, Ueki K, Tajima N, et al., Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer. Cancer Sci 2013; 104: 965-76.
5. Jee SH, Ohrr H, Sull JW, et al., Fasting serum glucose level and cancer risk in Korean men and women. Jama 2005; 293: 194-202.
6. Stocks T, Rapp K, Bjorge T, et al., Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 2009; 6: e1000201
7. Selvin E, Crainiceanu CM, Brancati FL, et al., Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007; 167: 1545-51.
8. Lin J, Ridker PM, Pradhan A, et al., Hemoglobin A1c concentrations and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2005; 14: 3010-2.
9. Wei EK, Ma J, Pollak MN, et al., Cpeptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 2006; 15: 750-5.
10. Platz EA, Hankinson SE, Rifai N, et al., Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control 1999; 10: 379-86.
11. Rinaldi S, Rohrmann S, Jenab M, et al., Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2008; 17: 3108-15.
12. Travier N, Jeffreys M, Brewer N, et al., Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study. Ann Oncol 2007; 18: 1414-9.
13. WCRF. World Cancer Research Fund. Food, nutrition, physical activity and the prevention of cancer: a global perspective (2nd edn.). World Cancer Research Fund/American Institute for Cancer Research, Washington, DC, USA 2007.
14. Goto M, Morita A, Goto A, et al., Reduction in adiposity, beta-cell function, insulin sensitivity, and cardiovascular risk factors: a prospective study among Japanese with obesity. PLoS One 2013; 8: e57964
15. Ikeda F, Doi Y, Yonemoto K, et al., Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 2009; 136: 1234-41.
16. Tsugane S, Sawada N., The JPHC Study: design and some findings on the typical Japanese diet. Jpn J Clin Oncol 2014; 44: 777-82.
17. Noda M, Kato M, Takahashi Y, et al., Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study-suggestion for the threshold for impaired fasting glucose among Japanese. Endocr J 2010; 57: 629-37.
18. Goto A, Noda M, Matsushita Y, et al., Hemoglobin a1c levels and the risk of cardiovascular disease in people without known diabetes: a population-based cohort study. In Japan. Medicine (Baltimore) 2015; 94: e785
19. Kashiwagi A, Kasuga M, Araki E, et al., International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012; 3: 39-40.
20. Currie CJ, Peters JR, Tynan A, et al., Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet 2010; 375: 481-9.
21. Riddle MC, Ambrosius WT, et al., Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010; 33: 983-90.
22. Zoungas S, Chalmers J, Ninomiya T, et al., Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 2012; 55: 636-43.
23. Marugame T, Yamamoto S, Yoshimi I, et al., Patterns of alcohol drinking and all-cause mortality: results from a large-scale population-based cohort study in Japan. Am J Epidemiol 2007; 165: 1039-46.
24. Ishihara J, Sobue T, Yamamoto S, et al., Validity and reproducibility of a self-administered food frequency questionnaire in the JPHC Study Cohort II: study design, participant profile and results in comparison with Cohort I. J Epidemiol 2003; 13: 134-47. S-.
25. Sasaki S, Ishihara J, Tsugane S., Reproducibility of a self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study Cohort I to assess food and nutrient intake. J Epidemiol 2003; 13: 115-24. S-.
26. Inoue M, Kurahashi N, Iwasaki M, et al., Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 2009; 18: 1746-53.
27. Inoue M, Iso H, Yamamoto S, et al., Daily total physical activity level and premature death in men and women: results from a large-scale population-based cohort study in Japan (JPHC study). Ann Epidemiol 2008; 18: 522-30.
28. World Health Organization. International classification of diseases for oncology, 3rd ed. Geneva: World Health Organization, 2000. vii, 240 p.
29. Selvin E, Steffes MW, Zhu H, et al., Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362: 800-11.
30. Grambsch PM, Therneau TM., Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-26.
31. Kurahashi N, Iwasaki M, Sasazuki S, et al., Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men. Br J Cancer 2006; 94: 740-2.
32. Joshu CE, Prizment AE, Dluzniewski PJ, et al., Glycated hemoglobin and cancer incidence and mortality in the Atherosclerosis in Communities (ARIC) Study, 1990-2006. Int J Cancer 2012; 131: 1667-77.
33. Saydah SH, Platz EA, Rifai N, et al., Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2003; 12: 412-8.
34. de Beer JC, Liebenberg L., Does cancer risk increase with HbA1c, independent of diabetes? Br J Cancer 2014; 110: 2361-8.
35. Aggarwal V, Schneider AL, Selvin E., Low hemoglobin A1c in nondiabetic adults: an elevated risk state? Diabetes Care 2012; 35: 2055-60.
36. Molinaro RJ., Targeting HbA1c: standardization and clinical laboratory measurement. MLO Med Lab Obs 2008; 40: 16-9.
37. Trenti T, Cristani A, Cioni G, et al., Fructosamine and glycated hemoglobin as indices of glycemic control in patients with liver cirrhosis. Ric Clin Lab 1990; 20: 261-7.
38. Christman AL, Lazo M, Clark JM, et al., Low glycated hemoglobin and liver disease in the U.S. population. Diabetes Care 2011; 34: 2548-50.
39. Sasazuki S, Inoue M, Iwasaki M, Otani, et al., Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2006; 15: 1341-7.
40. Hidaka A, Sasazuki S, Goto A, et al., Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Int J Cancer 2015; 136: 1402-10.
41. Knowler WC, Barrett-Connor E, Fowler SE, et al., Diabetes Prevention Program Research G. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
42. Tuomilehto J, Lindström J, Eriksson JG, et al., Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.
43. Kosaka K, Noda M, Kuzuya T., Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 2005; 67: 152-62.
44. Saito T, Watanabe M, Nishida J, et al., Zensharen Study for Prevention of Lifestyle Diseases G. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels:. A Randomized Controlled Trial. Arch Intern Med 2011; 171: 1352-60.
45. Centers for Disease Control and Prevention. National Diabetes Prevention Program, vol. 2015, 2015.